OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020

(By Maia Anderson for Becker’s Hospital Review)

OptumRx, the pharmacy benefit unit of UnitedHealth Group, released a list of the three drugs it expects to have the biggest impact on payers and patients in 2020.

Optum said it expects the emphasis on orphan drugs to continue this year and to make up nearly 40 percent of newly approved drugs across all disease categories. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org